These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8696875)

  • 21. Tight glycemic control? Negative.
    Raskin P
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():21-4; discussion 24-5. PubMed ID: 1347535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.
    Verrillo A; de Teresa A; Martino C; Verrillo L; di Chiara G
    Diabetes Res; 1988 Jun; 8(2):71-6. PubMed ID: 3067950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
    Rizvi AA; Petry R; Arnold MB; Chakraborty M
    Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of intensive treatment on diabetic retinopathy].
    Hanssen KF; Brinchmann-Hansen O; Dahl-Jørgensen K; Sandvik L
    Journ Annu Diabetol Hotel Dieu; 1988; ():167-73. PubMed ID: 3050220
    [No Abstract]   [Full Text] [Related]  

  • 27. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Diabetes Control and Complications Trial: new challenges for the primary physician.
    Clarke WL
    Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
    [No Abstract]   [Full Text] [Related]  

  • 29. Is tight blood sugar control effective and justified? Affirmative.
    Skyler JS
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():17-20; discussion 24-5. PubMed ID: 1347534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII).
    Olsen T; Ehlers N; Nielsen CB; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1985 Jun; 63(3):315-9. PubMed ID: 4036563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII).
    Hyer SL; Sharp PS; Sleightholm M; Burrin JM; Kohner EM
    Horm Metab Res; 1989 Jan; 21(1):18-22. PubMed ID: 2925151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary prevention of diabetic retinopathy in type I diabetes mellitus. Dependence on retinopathy status before the intervention].
    Maca T; Fasching P; Rohac M; Stur M; Schneider B; Waldhäusl W
    Dtsch Med Wochenschr; 1996 Mar; 121(9):257-62. PubMed ID: 8681772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Effect of Panretinal Photocoagulation on Spectral Domain Optical Coherence Tomography Measurements in Diabetic Retinopathy.
    Lee HJ; Kang TS; Kwak BS; Jo YJ; Kim JY
    Curr Eye Res; 2017 Aug; 42(8):1169-1173. PubMed ID: 28339297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Improvement of retinopathy in the diabetic treated with an intraperitoneal insulin pump].
    Zaluski S; Millet P; Selam JL
    J Fr Ophtalmol; 1985; 8(6-7):449-54. PubMed ID: 2416794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.